Ajanta Pharma releases Consolidated Quarterly Results for March 31, 2023. Ajanta Pharma has announced an increase in total income from Rs. 1006.70 Crores as of December 31, 2022, to Rs. 918.67 Crores as of March 31, 2023. The net profit for the company has decreased from Rs. 134.51 Crores as of December 31, 2022, to Rs. 122.25 Crores as of March 31, 2023. However, the earnings per share (EPS) have improved, increasing from Rs. 10.50 on December 31, 2022, to Rs. 9.54 on March 31, 2023, according to the company’s statement.
Ajanta Pharma Quarterly Results (Q4 FY2023) – Quarter-over-Quarter Comparison:
Total income of the company is Rs. 918.67 Crores (March 31, 2023) vs. Rs. 1006.70 Crores (December 31, 2022)
Net profit/loss: Rs. 122.25 Crores (March 31, 2023) vs. Rs. 134.51 Crores (December 31, 2022)
EPS: Rs. 9.54 (March 31, 2023) vs. Rs. 10.50 (December 31, 2022)
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹ 918.67 Cr | ₹ 1006.70 Cr | ⬇ -8.74% |
| Net Profit | ₹ 122.25 Cr | ₹ 134.51 Cr | ⬇ -9.11% |
| EPS | ₹ 9.54 | ₹ 10.50 | ⬇ -9.14% |
Ajanta Pharma Quarterly Results (Q4 FY2023) – Year-over-Year Comparison:
Total income of the company is Rs. 918.67 Crores (March 31, 2023) vs. Rs. 899.77 Crores (March 31, 2022)
Net profit/loss: Rs. 122.25 Crores (March 31, 2023) vs. Rs. 151.21 Crores (March 31, 2022)
EPS: Rs. 9.54 (March 31, 2023) vs. Rs. 11.66 (March 31, 2022)
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹ 918.67 Cr | ₹ 899.77 Cr | ⬆ 2.10% |
| Net Profit | ₹ 122.25 Cr | ₹ 151.21 Cr | ⬇ -19.15% |
| EPS | ₹ 9.54 | ₹ 11.66 | ⬇ -18.18% |
Ajanta Pharma Quarterly Results (Year Ended FY2023) – Year-over-Year Comparison:
Total income of the company is Rs. 3841.28 Crores (March 31, 2023) vs. Rs. 3456.67 Crores (March 31, 2022)
Net profit/loss: Rs. 587.98 Crores (March 31, 2023) vs. Rs. 712.68 Crores (March 31, 2022)
EPS: Rs. 45.89 (March 31, 2023) vs. Rs. 54.96 (March 31, 2022)
| Financials | 12 Months Ended FY2023 | 12 Months Ended FY2022 | % Change |
| Total Income | ₹ 3841.28 Cr | ₹ 3456.67 Cr | ⬆ 11.13% |
| Net Profit | ₹ 587.98 Cr | ₹ 712.68 Cr | ⬇ -17.50% |
| EPS | ₹ 45.89 | ₹ 54.96 | ⬇ -16.50% |
Ajanta Pharma Share Dividend Announcement / Record Date:
The dividend’s record date has not yet come
About Ajanta Pharma:
APL, or Ajanta Pharma Limited, is a multinational corporation located in India that focuses on the development, production, and promotion of pharmaceutical formulations. It has a widespread presence in approximately 30 other countries across Africa, Southeast Asia, West Asia, and the Commonwealth of Independent States, in addition to its operations in India and the United States.
Download Full PDF Q4 Results of Ajanta Pharma:
For More Latest News Click Here
